Clinical updates, including trial initiations, enrollment status and data readouts and publications: Baxter, Bioaffinity Technologies, Corwave, Inspiremd, Reflow Medical, Saranas.

Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: AACC, Akadeum, Calmare Therapeutics, Cota, Curadigm, Healgen, Helixbind, Hematogenix, Huma, Menarini Silicon Biosystems, Nanobiotix, Nanocellect, Neuspera, Orasure Technologies, Roche, Tyto Care, Vivera Pharmaceuticals.

Med-tech firms raising money in public or private financings, including: Cardiovascular Systems, Mesa Laboratories, Pulse Biosciences, Varex Imaging.

New hires and promotions in the med-tech industry, including: Inogen, Onlume, Pacific Biosciences of California, Renovacare, Rti Surgical Holdings, Scipher Medicine.

Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: 4web Medical, Atomic Blue, Dexcom, Hangzhou Biotest Biotech, Incelldx, Seasun Biomaterials, Sekisui Diagnostics, Vasoptic Medical.

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Bacainn, Curis, F2G, Fulcrum, Pharnext, Redhill, Rezolute, Vertex.

Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Adagene, Adgero, Alligator, Alphamab, Aptevo, Autotelic, Biocryst, Bryn, Bryologyx, Curadigm, Debiopharm, Delmar, Denali, Dyadic, E-therapeutics, Intomics, Izana, J&J, L.E.A.F., Lyvgen, Mateon, Melinta, Menarini, Merck, Metuchen, Midatech, Mitsubishi Tanabe, Nanobiotix, Nantkwest, Neurotrope, Orgenesis, Ose, Panacea, Pharmabcine, Qualigen, Refana, Secura, Stemline, Supernus, Takeda, Tetraphase, US Worldmeds, Zealand.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Abbvie, Biondvax, Catalyst, Dermata, Devonian, Impel, Merck, Opthea, Orpheris, Pfizer, Pulmatrix, Tychan.

Biopharmas raising money in public or private financings, including: Aileron, Amyris, Antibe, Appili, Applied Molecular Transport, Can-Fite, Fulcrum, Immunic, Innocan, Legend, Oncology Venture, Vedanta.

New hires and promotions in the biopharma industry, including: Azafaros, Confo, Gritstone, Legend, Oric, Tonix, Verrica.